Skip to main content

Advertisement

SpringerLink
Log in

Skeletal effects of parathyroid hormone (1–34) in ovariectomized rats with or without concurrent administration of salmon calcitonin

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

Abstract

This study evaluated the effect of parathyroid hormone (PTH) infusion alone or in combination with salmon calcitonin (sCT) in ovariectomized (OVX) rats and compared it with daily PTH injections alone or in combination with sCT infusion. Female Sprague-Dawley rats were divided randomly into 6 groups and were either bilaterally ovariectomized or underwent a sham operation; they were then treated for 4 weeks, beginning the day after surgery. Each group of OVX rats received either PTH infusion (group 1), PTH+sCT infusion (group 2), sCT infusion+daily PTH injection (group 3), or daily PTH injection (group 4). One group each of OVX (group 5) and sham-operated rats (group 6) received daily injections of vehicle alone. PTH was injected at 80 μg/kg/day and infused at 40 μg/kg/day, whereas sCT was infused at 10 μg/kg/day. The animals were sacrificed 28 days after treatment, and cancellous bone volume was measured in the tibial metaphysis. Similar to daily PTH injections, continuous infusion of PTH alone increased cancellous bone volume significantly over that seen in vehicle-treated OVX and sham-operated rats. Although cancellous bone volume after continuous infusion of PTH+sCT was also significantly higher than that seen in vehicle-treated OVX and sham-operated rats, the increase was significantly lower than with the other 3 nonvehicle treatments. The increase in cancellous bone volume after administration of sCT infusion along with daily PTH injections was not different from that with daily PTH injections alone. Thus, at the doses tested, the beneficial effects of PTH injection were not apparently improved by PTH infusion or by combination with sCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of parathyroid hormone on bone. Endoer Rev. 1993; 14: 690–709.

    CAS  Google Scholar 

  2. Lindsay R, Nieves J, Formica C, et al. Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet. 1997;350:550–555.

    Article  CAS  PubMed  Google Scholar 

  3. Morley R, Whitfield JF, Willick GE. Anabolic effects of parathyroid hormone on bone. Trends Endocrinol Metab. 1997;8:225–231.

    Article  CAS  PubMed  Google Scholar 

  4. Reeve J. PTH: a future role in the management of osteoporosis? J Bone Miner Res. 1996;11:440–445.

    Article  CAS  PubMed  Google Scholar 

  5. Whitfield JF, Morley P. Anabolic treatments for osteoporosis. Boca Raton: CRC Press; 1998.

    Google Scholar 

  6. Dobnig H, Turner R. The effects of programmed administration of human parathyroid hormone fragment (1–34) on bone histomorphometry and serum chemistry in rats. Endocrinology. 1997;138:4607–4612.

    CAS  PubMed  Google Scholar 

  7. Tam CS, Heersche JNM, Murray TM, Parsons JA. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology. 1982;110:506–512.

    Article  CAS  PubMed  Google Scholar 

  8. Hock JM, Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to PTH. J Bone Miner Res. 1992;7;65–72.

    Article  CAS  PubMed  Google Scholar 

  9. Uzawa T, Hori M, Ejiri S, Ozawa H. comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1–34) on rat bone. Bone. 1995;16:477–484.

    CAS  PubMed  Google Scholar 

  10. Kitazawa R, Imai Y, Fukase M, Fujita T. Effects of continuous infusion of PTH and PTH-related peptide on at bone in vivo: comparative study of histomorphometry. Bone Miner. 1991;12:157–166.

    Article  CAS  PubMed  Google Scholar 

  11. Wronski TJ, Walsh CC, Ignaszewski LA. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone. 1986;7:119–123.

    Article  CAS  PubMed  Google Scholar 

  12. Turner RT, Wakley GK, Hannon KS, Bell NH. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovariectomized hormone-deficient rats. Endocrinology. 1988;122:1146–1150.

    Article  CAS  PubMed  Google Scholar 

  13. Wronski TJ, Cintron M, Dann LM. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int. 1988;43:179–183.

    Article  CAS  PubMed  Google Scholar 

  14. Rixon RH, Whitfield JF, Gagnon L, et al. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res. 1994;9:1179–1189.

    Article  CAS  PubMed  Google Scholar 

  15. Whitfield JF, Morley P, Willick GE, et al. Stimulation of growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH (1–31)NH2 (Ostabolin). Calcif Tissue Int. 1996;58:81–87.

    Article  CAS  PubMed  Google Scholar 

  16. Heany RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med. 1978;92:964–970.

    Google Scholar 

  17. Delmas PD, Wahner HW, Mann KG, Riggs BL. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone gla-protein. J Lab Clin Med. 1983;102:470–476.

    CAS  PubMed  Google Scholar 

  18. Riis BJ, Rodbro P, Christinsen C. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcif Tissue Int. 1986;38:318–322.

    Article  CAS  PubMed  Google Scholar 

  19. Stepan JJ, Pospichal J, Presl J, Pacovsky V. Bone loss and biochemical indices of remodeling in surgically induced postmenopausal women. Bone. 1987;8:279–284.

    Article  CAS  PubMed  Google Scholar 

  20. Kalu DN, Liu CC, Hardin RR, Hollis BW. The aged model of ovarian hormone deficiency bone loss. Endocrinology. 1989;124:7–16.

    Article  CAS  PubMed  Google Scholar 

  21. Thompson DD, Simmons HA, Pirie CM, Ze HZ. FDA guidelines and animal models for osteoporosis. Bone. 1995;16:157–161.

    Article  Google Scholar 

  22. Morley P, Whitfield JF, Willick GE, et al. Prolonged low-dose infusion of human parathyroid hormone does not increase femoral cancellous bone volume in ovariectomized rats. Eur J Endocrinol. 1999;141:70–74.

    Article  CAS  PubMed  Google Scholar 

  23. Shen V, Birchman R, Wu DD, Lindsay R. Skeletal effects of parathyroid infusion in ovariectomized rats with or without estrogen repletion. J Bone Miner Res. 2000;15:740–746.

    Article  CAS  PubMed  Google Scholar 

  24. Zhou H, Shen V, Dempster DW, Lindsay R. Continuous parathyroid hormone and estrogen administration increase vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res. 2001;16:1300–1307.

    Article  CAS  PubMed  Google Scholar 

  25. Li M, Shen Y, Burton KW, et al. A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats. Bone. 1996;18(4):375–380.

    Article  PubMed  Google Scholar 

  26. Wronski TJ, Yen CF, Burton KW, et al. Skeletal effects of calcitonin in ovariectomized rats. Endocrinology. 1991;129:2246–2250.

    Article  CAS  PubMed  Google Scholar 

  27. Wronski TJ, Schenck PA, Cintron M, Walsh CC. Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int. 1987;40:155–159.

    Article  CAS  PubMed  Google Scholar 

  28. Gaggi R, Beltrandi E, Dall'Ollio R, Ferri S. Relationships between hypocalcemic and anorectic effect of calcitonin. Pharmacol Res Commun. 1985;17:209–215.

    Article  CAS  PubMed  Google Scholar 

  29. Yates AJ, Gutierrez GE, Garrett IR, et al. A noncyclical analog of salmon calcitonin (N-propionyl di-ala1,7 des-leu19 sCT) retains full potency without inducing anorexia in rats. Endocrinology. 1990;126:2845–2849.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Inhale Therapeutic Systems, 94070, San Carlos, CA

    Bhas A. Dani

  2. Faculty of Pharmaceutical Sciences, University of Kentucky, College of Pharmacy, 907 Rose Street, 40536, Lexington, KY

    Patrick P. DeLuca

Authors
  1. Bhas A. Dani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick P. DeLuca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick P. DeLuca.

Additional information

Published: November 16, 2001

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dani, B.A., DeLuca, P.P. Skeletal effects of parathyroid hormone (1–34) in ovariectomized rats with or without concurrent administration of salmon calcitonin. AAPS PharmSci 3, 27 (2001). https://doi.org/10.1208/ps030427

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/ps030427

Keywords

Search

Navigation